The global epilepsy drugs market was valued at USD 10 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 14.80 billion by 2032. The increasing prevalence of epilepsy will drive the growth of the global epilepsy drugs market.